ClinConnect ClinConnect Logo
Search / Trial NCT03969251

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder

Launched by NASSIMA AIT-DAOUD TIOURIRINE · May 28, 2019

Trial Information

Current as of May 22, 2025

Unknown status

Keywords

Alcohol Alcohol Dependence Addiction Alcohol Use Disorder

ClinConnect Summary

This is a randomized double- blind, control study.

To test the hypothesis, the investigator propose a 2 phase design:

Phase 1: 6-week trial comparing the efficacy of active high-frequency (HF) rTMS of L-DLPFC versus sham (SS) rTMS to determine if HF rTMS improves cognitive flexibility in recently detoxified alcoholics Phase 2: at the end of TMS phase, all participants will receive cognitive behavioral therapy (CBT) thus permitting participants with AUD to benefit from cognitive restructuring in CBT, and reduce alcohol cravings and drinking outcomes.

This study will recruit 20 individuals...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Right handed males and females who have given written informed consent.
  • Age 22 years and above with a history of alcohol use disorder
  • Good physical health
  • Have a current diagnosis of alcohol use disorder
  • Reports at least 4 "heavy drinking days" on average in the past 30 days.
  • Have a BAC by breathalyzer equal to 0.000 when the participants signed the informed consent document
  • Six months stability on any psychotropic medications
  • Not have any unresolved legal problems that could jeopardize continuation or completion of the study.
  • Be able to provide written informed consent, able to understand written and oral instructions in English and be able to complete the questionnaires required by the protocol.
  • Exclusion Criteria:
  • Please contact site for additional information.

About Nassima Ait Daoud Tiouririne

Nassima Ait-Daoud Tiouririne is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative study design and rigorous trial management. With a commitment to ethical practices and regulatory compliance, Nassima leads initiatives that explore new therapeutic options across various medical fields. Her expertise in clinical operations and strategic collaborations fosters an environment of excellence, ensuring that all trials not only adhere to the highest standards of scientific integrity but also prioritize participant safety and well-being. Through her leadership, Nassima Ait-Daoud Tiouririne aims to bridge the gap between research and real-world applications, contributing to the evolution of healthcare solutions.

Locations

Charlottesville, Virginia, United States

Patients applied

0 patients applied

Trial Officials

Nassima Ait-Daoud TIouririne, M.D.

Principal Investigator

University of Virginia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials